Skip to main content
Bismarck Christian Odei
( out of 146 reviews )

Bismarck Christian Odei, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106

Dr Bismarck Odei is a physician-scientist and an Assistant Professor in Genitourinary Cancers and Thoracic Cancers at the Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah. He completed his undergraduate degree in Chemical Engineering at Brigham Young University. He subsequently completed his medical training at UCLA School of Medicine in Los Angeles, California. He was a resident and chief resident at The Ohio State Department of Radiation Oncology.

Dr Odei is passionate about the success of his patients, and he is committed to effective patient care and education, and implementation of safe and cutting-edge technology to improve patient outcomes.

He is the recent recipient of the 2023 University of Utah GUCC Pilot Grant for prostate cancer research, and the highly-competitive Robert A. Winn Career Development Award, supported by the Bristol Myers Squibb Foundation. He is also the recent recipient of the American Cancer Society Institutional Research Grant and the Huntsman Cancer Foundation Innovation Award. He is also the site Principal Investigator in several national trials in Lung Cancer and Prostate Cancer. He also contributes to work in Cancer Survivorship including in areas such as psycho-oncology.

Dr Odei's work has been published in premier medical journals such as JAMA Internal Medicine, JAMA Network Open, and International Journal of Radiation Oncology, Biology, and Physics. He has presented his research at international conferences such as the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), and National Medical Association (NMA). Some of his research work has scored in the top 5% of all research outputs scored by Altmetric.

Outside of work he enjoys spending time with his wife and daughters, and volunteers in religious and community events.

Board Certification

American Board of Radiology (Radiation Oncology)

Patient Rating

Patients consistently describe the doctor as highly knowledgeable, thorough, and professional, which gives them confidence in his care. Reviewers emphasize clear communication, compassion, and approachability, noting he explains treatments well and takes time to answer questions. Many say he makes them feel safe and treated as an individual rather than a number, and that he is available when needed.

Generated via Patient Reviews

5.0 /5
( out of 146 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Apr 22, 2026
HUNTSMAN CANCER INSTITUTE

He'll treat you like a long lost friend, wanting only to care and help you.

Feb 03, 2026
HUNTSMAN CANCER INSTITUTE

Each of my interactions with this talented Doctor have been like visiting with a trusted friend. I am not just a number. He is really a talented young man

Feb 03, 2026
HUNTSMAN CANCER INSTITUTE

He makes sure I'm doing good and explaining everything to me so I understand it

Jan 28, 2026
SUGAR HOUSE HEALTH CENTER

He's very knowledgeable about prostate issues , and helped me decide what to do !

Dec 31, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Odei is very approachable, thorough, and communicates clearly. He always seems very knowledgeable about my case rather than dealing in generalities. He engenders trust.

Nov 22, 2025
HUNTSMAN CANCER INSTITUTE

Very professional, very knowledgeable, all-around good guy

Nov 19, 2025
SUGAR HOUSE HEALTH CENTER

Dr Bismarc Odei was very informative and very compassionate and we felt like he was not rushed and spent time answering all our questions.

Oct 29, 2025
SUGAR HOUSE HEALTH CENTER

I am glad I listened to him

Oct 26, 2025
HUNTSMAN CANCER INSTITUTE

Dr. Odei is very compassionate and reassuring. He explained coming treatments very well.

Oct 20, 2025
HUNTSMAN CANCER INSTITUTE

I feel totally safe in Dr. Odei's care.

Oct 11, 2025
HUNTSMAN CANCER INSTITUTE

Great guy

Sep 29, 2025
HUNTSMAN CANCER INSTITUTE

Brilliant and caring!

Aug 19, 2025
SUGAR HOUSE HEALTH CENTER

Professional, medically inclined, effective, effective listener, totally awesome!

Aug 03, 2025
HUNTSMAN CANCER INSTITUTE

Dr Odei is the best!!!

Feb 27, 2025
HUNTSMAN CANCER INSTITUTE

Dr Odei was thoughtful, attentive and answered all our questions. If we needed to talk to him he was available.

Nov 26, 2024
SUGAR HOUSE HEALTH CENTER

Dr. Odei is one of the best Doctors I have met. I have every confidence in him.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Board Certification and Academic Information

Academic Departments Radiation Oncology -Assistant Professor
Board Certification
American Board of Radiology (Radiation Oncology)

Education history

Residency Ohio State University College of Medicine (Radiation Oncology) Chief Medical Resident
Residency Ohio State University College of Medicine (Radiation Oncology) Resident
Internship Sanford Medical Center Transitional Internship (UND) Transitional Internship
David Geffen School of Medicine at UCLA Research Fellow
Professional Medical Medicine - David Geffen School of Medicine at UCLA M.D.
Undergraduate Chemical Engineering - Brigham Young University B.S.

Selected Publications

Journal Article

  1. Linares-Perdomo O, Klebe D, Chino F, Odei BC (2026). GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History. JAMA Netw Open, 9(10), e2637813.
  2. Crockett E, Schmidt B, Rodriguez O, Taylor A, Braun E, Leonhart S, Swami U, Boucher KM, Chapman L, Davis H, Linton J, Mangelson E, Johnson S, Tward J, Odei B, Yap J, Gupta S, Kohli M, Agarwal N, Dechet C, ONeil B, Maughan BL, Sanchez A (2026). Salvage Metastasis-Directed Therapy Without Androgen Deprivation for Positron Emission Tomography-Defined Oligorecurrent Prostate Cancer: Results of the SOAR Phase II Trial. JU Open Plus, 4(9), e00101.
  3. Odei B, Bae S, Paxton M, Richins B, McLeskey C, Linares-Perdomo O, Klebe D (2026). Legislative Trajectory of Mental Health and Substance Use-Focused Bills in the US Congress, 1989-2023. Health Aff Sch.
  4. Myint ZW, Yan D, St Clair W, Strup S, Hensley PJ, Allison DB, Martin FM, Kumar R, Selene II, Whitesell A, Odei B, Maughan BL (2026). Interim Safety Analysis of a Randomized Phase II Trial Comparing Pembrolizumab With Radiation Versus Pembrolizumab, Olaparib, and Radiation in Localized High-Risk Prostate Cancer. JCO Oncol Adv.
  5. Linares-Perdomo O, Klebe D, Odei BC (2026). Factors associated with serious psychological distress among US adult cancer survivors: a cross-sectional observational analysis of the 2024 National Health Interview Survey. J Cancer Surviv.
  6. Sung D, Rooney MK, Sulaimon L, Jagsi R, Chino F, Spector N, Suneja G, Shorter B, Fagerlin A, Taparra K, Nielson M, Odei BC (2026). Composition by Sex of State and Federal Legislative Health Committees. JAMA Netw Open, 9(5), e2613624.
  7. Odei BC, Agabalogun T, Bello-Pardo E, Huang C, Vanderbilt D, Omeh S, Sterling B, Chino F (2025). Representation of Radiation Oncologists on National Comprehensive Cancer Network Guideline Committees. Adv Radiat Oncol, 10(6), 101773.
  8. Kalathoor S, Ghazi S, Otieno B, Babcook M, Chen S, Nidhi N, Bae J, Pierre-Charles J, Breathett K, Mazimba S, Johnson A, Brewer L, Mohammed S, Carter R, Bonsu J, Ferdousi M, Kola-Kehinde O, McLaughlin E, Brammer J, Ruz P, Khan S, Odei B, Mitchell D, Wei L, Patel P, Paskett E, and Addison D (2024). Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies. International Journal of Cancer.
  9. Hutten RJ, Odei B, Johnson SB, Tward JD (2024). Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers. JCO Precis Oncol, 8, e2300364.
  10. Odei BC, Herrera S, Huang C, Griffith KA, Bae J, Lastra AZ, Jagsi R (2024). Portrayal of Women as Physicians in Movies, 1990-2020. JAMA Intern Med, 183(10), 1168-1170.
  11. Odei BC, Pan X, Bello-Pardo E, Mitchell D, Thomas CR Jr, Diaz DA (2022). Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists. Am J Clin Oncol, 45(3), 112-115.
  12. Odei BC, Seldon C, Fernandez M, Rooney MK, Bae J, Acheampong J, Ahmed A (2021). Representation of Women in the Leadership Structure of the US Health Care System. JAMA Netw Open, 4(11), e2136358.
  13. Odei B, Kahn J, Holliday EB, Diaz DA, Bello-Pardo E, Odei J, Bae J, Arnett A, Raval R, Mitchell D (2021). Where Are the Women in Radiation Oncology? A Cross-Sectional Multi-Specialty Comparative Analysis. Adv Radiat Oncol, 6(5), 100735.
  14. Odei BC, Jagsi R, Diaz DA, Addison D, Arnett A, Odei JB, Mitchell D (2021). Evaluation of Equitable Racial and Ethnic Representation Among Departmental Chairs in Academic Medicine, 1980-2019. JAMA Netw Open, 4(5), e2110726.
  15. Odei BC, Gawu P, Bae S, Fabian D, Odei J, Lee C, Mitchell D (2020). Evaluation of Progress Toward Gender Equity Among Departmental Chairs in Academic Medicine. JAMA Intern Med, 181(4), 548-550.
  16. Xiao H, Odei B, Clinton S, Mitchell D (2021). The potential role of DEK over-expression in the radiation response of head and neck cancer. Radiat Med Prot.
  17. Odei B, Holliday EB, Jagsi R, Chino F, Schulmire C, Kudrimoti M, Chen AM, Raval R, Fabian D (2020). Recruitment Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. Int J Radiat Oncol Biol Phys, 109(2), 637-638.
  18. Odei B, Quick A (2020). The implications of COVID-19 in radiation oncology in the United States. Curr Oncol, 27(5), 279-280.
  19. Odei B, Rwigema JC, Eilber FR, Eilber FC, Selch M, Singh A, Chmielowski B, Nelson SD, Wang PC, Steinberg M, Kamrava M (2017). Predictors of Local Recurrence in Patients With Myxofibrosarcoma. Am J Clin Oncol, 41(9), 827-831.
  20. Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK (2017). Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. Am J Clin Oncol, 41(8), 784-791.
  21. Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney DK (2017). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk, 17(12), 819-824.
  22. Boothe D, Williams N, Odei B, Poppe MM, Werner TL, Suneja G, Gaffney DK (2017). The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care. Int J Gynecol Cancer, 27(5), 912-922.
  23. Odei BCL, Boothe D, Keole SR, Vargas CE, Foote RL, Schild SE, Ashman JB (2017). A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy. Int J Part Ther, 3(3), 398-406.
  24. Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe MM (2016). Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Int J Radiat Oncol Biol Phys, 97(1), 60-63.
  25. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, L Werner T, Gaffney DK (2016). Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427]. Gynecol Oncol, 143(3), 690-691.
  26. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney DK (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecol Oncol, 141(3), 421-427.
  27. Odei BC, Boothe D, Lloyd S, Gaffney DK (2016). A comprehensive analysis of brachytherapy clinical trials over the past 15 years. Brachytherapy, 15(6), 679-686.

Review

  1. Anaba U, Ishola A, Alabre A, Bui A, Prince M, Okafor H, Kola-Kehinde O, Joseph JJ, Mitchell D, Odei BC, Uzendu A, Williams KP, Capers Q 4th, Addison D (2021). Diversity in modern heart failure trials: Where are we, and where are we going. [Review]. Int J Cardiol, 348, 95-101.

Commentary

  1. Odei B, Das P, Pinnix C, Raval R, Holliday EB (2020). Potential Implications of the New USMLE Step 1 Pass/Fail Format for Diversity Within Radiation Oncology. Adv Radiat Oncol, 6(1), 100524.

Editorial

  1. Odei BC, Thomas CR Jr (2026). Automatic Tenure-Clock Extensions as a Safeguard Against Defunding. Ann Intern Med.
  2. Hutten RJ, Odei B, Rivera A, Suneja G (2022). Achieving Health Equity in Radiation Oncology-Moving From Awareness to Action. Int J Radiat Oncol Biol Phys, 114(2), 195-197.

Letter

  1. Odei BC, Mitchell D (2023). The Asian Glass Ceiling in Academic Medical Leadership. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 116(2), 213.
  2. Odei BC, Chino F, Mitchell D (2021). A Charge to Academic Chairs-Reply. [Letter to the editor]. JAMA Intern Med, 181(8), 1136-1137.
  3. Odei BC, Bae J, Littman D, Lastra AZ, Morgan A, Agabalogun T, Herrera S, Odei J, Fabian D, Chino F (2021). Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 110(3), 919-921.
  4. Odei B, Bae S, Diaz DA (2020). Challenges influencing the utilization of prostate brachytherapy in the United States. [Letter to the editor]. Radiother Oncol, 154, 123-124.

News & Podcasts